Skip to main content
MASIMO CORP logo

MASIMO CORP — Investor Relations & Filings

Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Open in API
Filings indexed 1,253 across all filing types
Latest filing 2017-07-13 Director's Dealing
Country US United States of America
Listing US MASI

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2017-07-13 English
Regulatory Filings 2017
Regulatory Filings
2017-07-10 English
Regulatory Filings 2017
Regulatory Filings Classification · 80% confidence The document text is heavily encoded or encrypted and does not contain any readable content, keywords, or identifiable regulatory references. The metadata indicates the document length is 7,815 characters, which is sufficient to contain a substantive report if it were readable. However, due to the unreadable nature of the text, it is impossible to classify it as a specific report type such as Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). There is no indication that this is a short announcement or certification either. Given the lack of readable content and inability to identify the document type, the best classification is Regulatory Filings (RNS), which serves as a fallback category for miscellaneous or unclassifiable filings.
2017-07-10 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by Masimo Corporation. It registers shares of common stock under the Masimo Corporation 2017 Equity Incentive Plan. The document includes details about the registration fee, incorporation by reference of prior filings (including 10-K, 10-Q, and 8-K), and legal provisions related to indemnification of directors and officers. Form S-8 is a registration statement used for securities issued under employee benefit plans and is not a financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration and compliance with the Securities Act of 1933. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is substantial (15,000 characters), and it is not merely an announcement or certification but a full registration statement filing.
2017-07-08 English
S-8 POS
Transaction in Own Shares Classification · 95% confidence The document is a Post-Effective Amendment No. 1 to multiple Form S-8 Registration Statements filed with the SEC by Masimo Corporation. It discusses deregistration of shares under prior S-8 filings related to the company's 2007 Stock Incentive Plan and the transition to a new 2017 Equity Incentive Plan. The document is regulatory in nature, dealing with registration and deregistration of securities for employee stock plans. It does not contain financial statements, earnings data, management discussion, or other report content. It is a formal SEC filing related to securities registration amendments, which fits the category of Transaction in Own Shares (POS) filings, as it relates to stock incentive plans and share registration changes. The document length is 8567 characters, which is substantive and not a mere announcement. Therefore, the best classification is POS (Transaction in Own Shares).
2017-07-08 English
S-8 POS
Transaction in Own Shares Classification · 95% confidence The document is a Post-Effective Amendment No. 1 to multiple Form S-8 Registration Statements filed with the SEC by Masimo Corporation. Form S-8 is used for registering securities to be offered under employee benefit plans, such as stock incentive plans. The document discusses deregistration of shares under prior registration statements and the transition from the 2007 Stock Incentive Plan to the 2017 Equity Incentive Plan. It is a regulatory filing related to securities registration and amendments, not a financial report, earnings release, or other report types. The document is about capital structure changes related to stock incentive plans and share registration/deregistration. Therefore, the most appropriate classification is Transaction in Own Shares (POS), which covers share repurchase/issuance and related filings. The document length and content confirm it is not a brief announcement but a substantive filing. Confidence is high due to clear SEC form references and content focus on share registration amendments under stock plans.
2017-07-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.